Why the study?
Does long-term treatment with endothelin receptor antagonists improve survival and alterations in cardiac gene expression in rats with heart failure?
Population
Rats with chronic heart failure (CHF) and control sham-operated rats
Comparison
BQ-123 (ET receptor antagonist) or SB209670 (ET… vs Saline (vehicle) administered for 3 months
Design
Preclinical
Follow-up
3 months
Authors
Loading...
Endothelin antagonists may improve survival in rat CHF models; extends prior preclinical data but leaves open human translation.
Does long-term treatment with endothelin receptor antagonists improve survival and alterations in cardiac gene expression in rats with heart failure?
Long-term treatment with endothelin receptor antagonists improves survival and prevents molecular changes in the failing hearts of rats with chronic heart failure.
Sakai et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: